BevacizumabWorsened hypertension: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1776卷 / 1期

关键词：

D O I：

10.1007/s40278-019-70257-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：99 / 99

相关论文

共 50 条

[1] BevacizumabArterial hypertension: 2 case reports
Reactions Weekly, 2023, 1947 (1) : 105 - 105
[2] MethylphenidatePulmonary hypertension: 2 case reports
Reactions Weekly, 2015, 1578 (1) : 200 - 200
[3] AntineoplasticsThrombocytopenia and hypertension: 2 case reports
Reactions Weekly, 2022, 1907 (1) : 63 - 63
[4] AntiretroviralsPulmonary hypertension: 2 case reports
Reactions Weekly, 2002, 915 (1) : 5 - 5
[5] BevacizumabPulmonary hypertension: 2 case reports
Reactions Weekly, 2009, 1280 (1) : 11 - 11
[6] RamucirumabAcute hypertension: 2 case reports
Reactions Weekly, 2016, 1622 (1) : 167 - 167
[7] DexamethasoneOcular hypertension: 2 case reports
Reactions Weekly, 2019, 1768 (1) : 127 - 127
[8] DiazoxidePulmonary hypertension: 2 case reports
Reactions Weekly, 2019, 1766 (1) : 119 - 119
[9] BevacizumabAllergy and hypertension: 2 case reports
Reactions Weekly, 2017, 1662 (1) : 72 - 72
[10] DifluprednateOcular hypertension: 2 case reports
Reactions Weekly, 2022, 1907 (1) : 178 - 178

← 1 2 3 4 5 →